Zymeworks Inc. (ZYME) Fundamentals

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of differentiated product candidates. Its lead clinical candidate, zanidatamab, is a novel Azymetric HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
SHARE INFORMATION
Market Cap$ 389,618,443
Shares Outstanding39,309,157
Float57,861,125
Percent Float99.95%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 26,666,519
Latest Fiscal EPS$ -4.37
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions263
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months18,857,662
Institutional Holdings Percent109.4%
Institutional Sold Previous 3 Months19,414,092
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months203,050
Insider Holdings Percent0.8
Insider Sold Previous 3 Months-
Insider Shares Owned481,461
TRADING INFO
52 Week High$ 37.19
52 Week Low$ 4.56
52 Week High Change$ -80.17
21 Day Moving Average$ 6.08
21 Day Extended Moving Average$ 6.2015
50 Day Moving Average$ 6.1466
50 Day Extended Moving Average$ 6.165
200 Day Moving Average$ 10.1979
200 Day Extended Moving Average$ 11.3488
10 Day Average Volume967,179
20 Day Average Volume872,397
30 Day Average Volume1,027,914
50 Day Average Volume1,075,350
Alpha0.003429
Beta1.1292
Standard Deviation0.198483
R20.080964
7 Day Price Change$ 0.59
7 Day Percent Change9.61%
21 Day Price Change$ 0.56
21 Day Percent Change9.08%
30 Day Price Change$ 0.23
30 Day Percent Change3.54%
Month to Date Price Change$ 0.89
Month to Date Percent Change15.24%
Quarter to Date Price Change$ 1.43
Quarter to Date Percent Change26.98%
180 Day Price Change$ -1.34
180 Day Percent Change-16.6%
200 Day Price Change$ -4.48
200 Day Percent Change-39.96%
Year to Date Price Change$ -9.66
Year to Date Percent Change-58.94%

Zymeworks Inc. (ZYME) Key Ratios

PROFITABILITY
EBIT Margin-760.1%
EBITDA Margin-723.1%
Pre-Tax Profit Margin-248.9%
Profit Margin Count0.0%
Gross Margin-30.7%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 31,609,519
Revenue Per Share$ 0.546
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book2.20
Total Debt To Equity0.10
Int Coverage0.00
Current Ratio3.30
Leverage Ratio1.60
Quick Ratio3.10
Long Term Debt To Capital0.12
VALUATION MEASURES
PE Ratio-1.60
Enterprise Value$ 195,424,495
Price to Sales12.326
Price to Free Cash-1.70
PE High Last 5 Years-8.20
Price To Book1.80
Price To Cash Flow310.40
PE Low Last 5 Years-17.10
Price to Tangible Book2.20
MANAGEMENT EFFECTIVENESS
Receivables Turnover3.40
Invoice Turnover0.00
Assets Turnover0.10
Return Assets-60.30
Return on Equity-93.60
Return on Capital-78.45

Zymeworks Inc. (ZYME) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorKPMG LLP
CEOKenneth Galbraith
Emplyoees327
Last AuditUQ
CIK0001403752
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address1385 West 8th Avenue
Suite 540
Vancouver, BC V6H 3V9
Websitehttp://www.zymeworks.com
Facsimile+1 604 737-7077
Telephone+1 604 678-1388
Emailir@zymeworks.com


Your Recent History
NYSE
ZYME
Zymeworks
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.